These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19126947)

  • 21. The metabolic approach in patients with heart failure: effects on left ventricle remodeling.
    Tang WH
    Curr Pharm Des; 2009; 15(8):850-6. PubMed ID: 19275649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Contribution of vastarel 20 mg (trimetazidine) in the treatment of vertigo: synopsis of clinical trials].
    Bouccara D
    Ann Otolaryngol Chir Cervicofac; 1999 Apr; 116(1):43-6. PubMed ID: 10367069
    [No Abstract]   [Full Text] [Related]  

  • 23. Prognostic relevance of metabolic approach in patients with heart failure.
    Di Napoli P; Barsotti A
    Curr Pharm Des; 2009; 15(8):883-92. PubMed ID: 19275652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic treatment of myocardial ischaemia.
    Ferrari R
    Eur Heart J; 1999 Aug; 20(16):1144-5. PubMed ID: 10448019
    [No Abstract]   [Full Text] [Related]  

  • 25. Meeting the challenge of chronic ischaemic heart disease with trimetazidine.
    Marzilli M; Affinito S
    Coron Artery Dis; 2005 Nov; 16 Suppl 1():S23-7. PubMed ID: 16340400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Modulation of myocardial metabolism with trimetazidine].
    Kölbel F
    Vnitr Lek; 2006 Jun; 52(6):558-9. PubMed ID: 16871756
    [No Abstract]   [Full Text] [Related]  

  • 27. Flosequinan: a new vasodilator for the treatment of heart failure.
    Dutka DP; Cleland JG
    Br J Hosp Med; 1993 May 5-18; 49(9):654-5. PubMed ID: 8508260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rationale and benefits of trimetazidine by acting on cardiac metabolism in heart failure.
    Lopatin YM; Rosano GM; Fragasso G; Lopaschuk GD; Seferovic PM; Gowdak LH; Vinereanu D; Hamid MA; Jourdain P; Ponikowski P
    Int J Cardiol; 2016 Jan; 203():909-15. PubMed ID: 26618252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vasodilator treatment of heart failure.
    Taylor SH
    Practitioner; 1981 Oct; 225(1360):1419-29. PubMed ID: 7329932
    [No Abstract]   [Full Text] [Related]  

  • 30. [Peripheral vasodilators in the treatment of heart failure].
    Ol'binskaia LI
    Farmakol Toksikol; 1989; 52(2):116-22. PubMed ID: 2744139
    [No Abstract]   [Full Text] [Related]  

  • 31. Re: Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy.
    Scheuer J
    Circulation; 2009 Mar; 119(11):e371; author reply e372. PubMed ID: 19307483
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of stable angina pectoris with trimetazidine].
    Meluzín J
    Vnitr Lek; 2006 Jun; 52(6):556-7. PubMed ID: 16871755
    [No Abstract]   [Full Text] [Related]  

  • 33. The use of placebo controls.
    Gilbert EM; Packer M
    N Engl J Med; 1995 Jan; 332(1):61; author reply 62. PubMed ID: 7990875
    [No Abstract]   [Full Text] [Related]  

  • 34. Metabolic agents in the management of diabetic coronary patients: a new era.
    Celik T; Kursaklioglu H; Iyisoy A; Jata B
    Int J Cardiol; 2008 Jun; 127(1):133-4. PubMed ID: 17561287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood pressure in heart failure: a love-hate relationship.
    Pfeffer MA
    J Am Coll Cardiol; 2007 Jan; 49(1):40-2. PubMed ID: 17207720
    [No Abstract]   [Full Text] [Related]  

  • 36. Metabolic therapy for heart disease: impact of trimetazidine.
    Sabbah HN; Stanley WC
    Heart Fail Rev; 2005 Dec; 10(4):281-8. PubMed ID: 16583176
    [No Abstract]   [Full Text] [Related]  

  • 37. Vasodilator therapy for decompensated heart failure.
    Yancy CW
    J Am Coll Cardiol; 2008 Jul; 52(3):208-10. PubMed ID: 18617069
    [No Abstract]   [Full Text] [Related]  

  • 38. Vasodilator therapy in cardiac failure what was new is old.
    O'Rourke MF; Nichols WW
    J Am Coll Cardiol; 2009 Mar; 53(10):898; discussion 898-99. PubMed ID: 19264253
    [No Abstract]   [Full Text] [Related]  

  • 39. Reversible Parkinsonism linked to trimetazidine (continued).
    Prescrire Int; 2006 Aug; 15(84):136. PubMed ID: 16989026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trimetazidine and reperfusion injury.
    Soler-Soler J; García-Dorado D
    Eur Heart J; 2001 Jun; 22(11):975; author reply 978. PubMed ID: 11428825
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.